MedPath
NMPA Approval

Liraglutide Injection

国药准字S20233109

June 30, 2023

Drug Information

利拉鲁肽注射液

利鲁平

注射剂

3ml:18mg(预填充注射笔)

生物制品

June 30, 2023

Company Information

Applicant Company

杭州市莫干山路866号祥符桥

Manufacturing Company

杭州经济技术开发区八号大街东

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利拉鲁肽注射液 - NMPA 批准文号 | MedPath